With insights from the crystal structural studies and further understanding of the assembly and composition of the CRTC/CREB transcriptional complex, new approaches can be developed to inhibit the oncogenic CRTC/CREB transcriptional program and block the progression of lung cancers. Here, CREB1 is linked to lung cancer.